The stimulation of FXR by BAs, in addition to self-regulating the composition of BAs, can lead to the modulation of several transcription factors associated with lipogenesis, inflammation, and fibrosis, all of which are well-known inherent features of NAFLD/MASLD [31,32,33,34]. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.